Enbrel Phase III Data Shows Significant Improvement In Pediatric Psoriasis
This article was originally published in The Pink Sheet Daily
Executive Summary
Enbrel could be the first biologic to treat pediatric patients' chronic moderate to severe plaque psoriasis.